Insulet
PODD
#1880
Rank
A$16.42 B
Marketcap
A$237.07
Share price
2.94%
Change (1 day)
-48.30%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): A$0.69 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.90 Billion. In 2025 the company made an earning of A$0.57 Billion, an increase over its 2024 earnings that were of A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.69 B21.48%
2025 A$0.57 B16.3%
2024 A$0.49 B36.76%
2023 A$0.36 B481.9%
2022 A$62.12 M-45.24%
2021 A$0.11 B43.35%
2020 A$79.12 M18.51%
2019 A$66.77 M41.16%
2018 A$47.3 M-711.95%
2017 -A$7.73 Million-56.85%
2016 -A$17.92 Million-79.31%
2015 -A$86.61 Million63.85%
2014 -A$52.86 Million31.04%
2013 -A$40.34 Million-21.96%
2012 -A$51.69 Million
2010 -A$49.3 Million-42.38%
2009 -A$85.56 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$77.61 Million209.75%
2006 -A$25.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.44 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.72 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.04 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$44.86 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.29 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.14 B-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.75 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA